United States· US:17156-026_3475dd6d-4e62-4907-9c45-00845816577f

Myoview

A medicinal product containing tetrofosmin, registered in United States by Medi-Physics Inc. dba GE Healthcare.

US label

Checked against FDA National Drug Code directory (United States) on

Informational only — not a medical device.

SOURCE REGISTER · USFDA National Drug Code directory (Unite…normalisedMyoviewATC—REGISTER NO.US:17156-026_3475dd6d…PACKS LISTED2CHECKEDSeptember 27, 2026

The record

At a glance

FDA National Drug Code directory (United States)
Active substance
TETROFOSMIN
Manufacturer
Medi-Physics Inc. dba GE Healthcare
Country
United States (US)
ATC code
—
Reimbursed
Not published by this register
Source register
FDA National Drug Code directory (United States)
Last checked
September 27, 2026

Packs & prices · 2

  • ndc11
    1715602630
    5 VIAL in 1 KIT (17156-026-30) / 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 VIAL
  • ndc11
    17156-026-30

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Tetrofosmin in 12 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All tetrofosmin products

Authorised across Europe · EMA

The same active substance is authorised in 22 EEA countries. Names it is sold under:

  • Austria · Myoview, Tetrofosmin Rotop
  • Belgium · Myoview, Tetrofosmin Rotop
  • Bulgaria · Майовю
  • Cyprus · Myoview
  • Czechia · Myoview
  • Germany · Myoview, Tetrofosmin Rotop
  • Denmark · Myoview
  • Spain · Myoview, Tetrofosmina Rotop
  • Finland · Myoview, Tetrofosmin Rotop
  • France · Myoview
  • United Kingdom (Northern Ireland) · Myoview, Tetrofosmin Rotop
  • Greece · Myoview, Tetrofosmin Rotop
  • Hungary · Myoview
  • Ireland · Myoview
  • Italy · Myoview
  • Luxembourg · Myoview
  • Malta · Myoview
  • Netherlands · Myoview, Tetrofosmine Rotop
  • Norway · Myoview
  • Portugal · Myoview, Tetrofosmina Rotop
  • Sweden · Myoview, Tetrofosmin Rotop
  • Slovakia · Myoview

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/36acdba2-670d-4a10-aa76-f29d427b57b6
GET /v1/drugs/36acdba2-670d-4a10-aa76-f29d427b57b6?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "route": "INTRAVENOUS",
  "source": "ndc",
  "strength": "1.38",
  "substance": "TETROFOSMIN",
  "productndc": "17156-026",
  "dosage_form": "INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION",
  "dea_schedule": null,
  "strength_unit": "mg/1",
  "application_number": "NDA020372",
  "marketing_category": "NDA"
}

See everything about tetrofosmin.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.